OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14

Showing 14 citing articles:

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 17

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Daniel H. Ahn, Afsaneh Barzi, Maya Ridinger, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2039-2047
Open Access | Times Cited: 16

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7

Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
David Johnson, Cheng Ean Chee, Wesley P. Wong, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102700-102700
Closed Access | Times Cited: 5

Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access

Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor models
Daniela Farias de Nóbrega, Logan C. Eiler, Parmanand Ahirwar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine
Gideon T Dosunmu, Ardaman Shergill
Genes (2024) Vol. 15, Iss. 5, pp. 538-538
Open Access | Times Cited: 2

KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
Annie Xiao, Marwan Fakih
Clinical Colorectal Cancer (2024) Vol. 23, Iss. 3, pp. 199-206
Closed Access | Times Cited: 1

Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?
Patrick W. Underwood, Timothy M. Pawlik
Cancers (2024) Vol. 16, Iss. 22, pp. 3870-3870
Open Access | Times Cited: 1

Closing Editorial: Colorectal Cancer—A Molecular Genetics Perspective
Ehsan Gharib
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12604-12604
Open Access | Times Cited: 1

Preclinical Evaluation of [124I]-Sotorasib for the Imaging of Kirsten Rat Sarcoma G12C Mutant Tumors
Raik Artschwager, Teja Kalidindi, Delissa S. Johnson, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3867-3878
Closed Access | Times Cited: 1

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways
Silvia García-Román, Mónica Garzón‐Ibáñez, Jordi Bertran‐Alamillo, et al.
Translational Oncology (2024) Vol. 40, pp. 101878-101878
Open Access

Page 1

Scroll to top